Abstract. The aim of this study was to investigate tumor biomarker carbohydrate antigen 724 (CA724) in the serum of patients with carcinomas of the colon and rectum at various clinical stages. Serum was collected from 51 patients with colon carcinoma (CC) and 49 patients with rectal carcinoma (RC). CA724 levels were then measured in the different groups according to site, TNM classification, gender, age and metastastic status of the patients. The statistical significance of the differences between the groups was calculated by non-parametric statistics (Mann-Whitney and Kruskall-Wallis tests). We observed a close association between the serum CA724 levels and tumor migration in colorectal carcinoma (CRC) and opposite variation tendencies of CA724 in the evolution of CC and RC. In conclusion, we identified a close association between the serum levels of CA724 and tumor migration in CRC. The opposite variation tendencies of CA724 in the different evolution groups of CC and RC may reflect the differences between these two types of cancer. The evaluation of serum CA724 may be of monitoring and and predictive value and may also assist in the development of treatment strategies for CRC patients.
Introduction
Colorectal carcinoma (CRC) remains one of the most common malignancies worldwide and represents a global health problem (1) . An increasing number of Asian countries, including China, Japan, South Korea and Singapore, have experienced a 2-to 4-fold increase in the incidence of CRC over the last few decades (2) . The pathogenesis of CRC ordinarily occurs in a staged progression from normal colonic mucosa to adenoma and finally to carcinoma over a period of ~7-10 years (3) (4) (5) . This sequenced progression over time provides an opportunity for early diagnosis and treatment.
It has previously been indicated that delayed diagnosis is the main reason for a poor prognosis (6) . The traditional non-invasive and invasive methods of screening modalities include fecal occult blood testing, fecal immunochemical test, double-contrast barium enema, flexible sigmoidoscopy and colonoscopy (7) (8) (9) . Although some of these screening modalities have been demonstrated to reduce the rates of malignancy or mortality, there remains the issue of reducing cancer-related mortality by removing premalignant adenomas and early localized cancer prior to the onset of more advanced stages. Therefore, an effective approach to early screening, diagnosis and follow-up monitoring of CRC is required.
Over the last few years, extensive investigations have focused on serum tumor markers (STMs). In patients with CRC, single STMs exhibit low sensitivity and specificity, whereas the simultaneous measurement of several STMs may increase their diagnostic accuracy (10) . It was demonstrated that the combined use of carcionembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 was effective in the screening and diagnosis of CRC (11) . CA724 was previously identified as a type of STM specific for gastric cancer (12) and the correlation between CA724 and CRC has been attracting increasing attention (13) .
Furthermore, due to the numerous characteristics shared by colon carcinoma (CC) and rectal carcinoma (RC), the two are discussed as a single entity. Whether CC and RC should be considered as a single or two distinct entities remains controversial (14) . Statistical analysis. The CA724 levels were assessed in different groups according to different site, TNM classification, gender, age and metastatic status of the patients. Since the serum CA724 levels in each group did not follow a normal distribution, the statistical significance of the differences between the groups was calculated by non-parametric statistics (Mann-Whitney and Kruskall-Wallis tests). The centralized tendency of each group was described as means plus standard error of the mean (SEM). All statistical tests were performed using SPSS software, version 11.5 (SPSS Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Differences among CRC patients in different groups.
The mean serum CA724 values ± SEM were 6.808±1.462 U/ml in CC patients and 5.524±1.151 U/ml in RC patients, with no statistically significant difference. Therefore, we first analyzed the two types of cancer as a single entity. The different CA724 levels among CRC patients in different groups are presented in Table II . The differences in the CA724 values between CRC clinical stages were compared (Fig. 1 ). Further investigations indicated that the mean serum CA724 concentrations ± SEM in patients with early-and advanced-stage disease were 5.414±1.317 and 6.689±1.281 U/ml, respectively. The differences between the two groups were not statistically significant. However, the differences between the CRC patient group with and that without distant metastasis was statistically significant (P=0.043).
To determine whether gender and age affected the results in CRC patients mentioned above, the differences in the serum CA724 values between genders was also assessed. Table III shows that there were no significant differences between male and female CRC patients. Furthermore, there were no significant differences between CRC patients aged 30-50 years and those aged >50 years. Therefore, the variables of gender and age were eliminated (Table II) . Since there were distinct differences among CRC patients, in order to interpret the differences described above when assessing the two groups as a single entity, we proceeded to analyze CC and RC separately.
Ascending gradient among CC patients. The different CA724 levels among CC patients in different groups are presented in Table V . Therefore, a descending gradient was identified among RC patients when each clinical stage was separately analyzed (Fig. 3) . Similarly, analysis with SPSS software, version 11.5, revealed a significant correlation between early-and advanced-stage disease (P=0.010). However, the differences in the CA724 values between patients with and those without distant metastasis did not reach a statistical significance (Fig. 3) . 
Discussion
This comprehensive integrative analysis of 100 CRC patients indicated that serum CA724 levels may be of predictive value in CRC, particularly in the analysis of clinical stage. As regards CA724, recent studies have mainly focused on the sensitivity and specificity of its diagnostic and early detection value for recurrences. The combinations of CA724 with other STMs were considered to be satisfactory (10, 13, (15) (16) (17) . In our study, we focused on the differences in the CA724 levels among patients with different disease stages. The differences in serum CA724 values between patients with early-and advanced-stage disease suggest that CA724 may be associated with the metastasis of CC and RC. A similar association was observed between CEA levels and CRC metastasis (18, 19) . When comparing and analysing CC and RC, we may surmise that the differences in the serum levels of CA724 represent a sign of distant metastasis in CC. However, we did not observe a statistically significant difference between RC patients with and those without distant metastasis. We then compared the clinical stages of CC and RC. Although we were unable to verify a statistically significant difference for each stage transition, there was a distinct variation tendency among the stages. Therefore, we consider that monitoring serum CA724 levels may be indicative of clinical stage, particularly in patients for whom the determination of the pathological stage is difficult. The CA724 value may reflect advanced stage, progression and metastasis of CRC. Due to the widely variable prognosis of CRC, a previous study attempted to identify a parameter useful in the selection of patients who may be candidates for more tailored treatment (20) . Whether CA724 is such a parameter requires further verification; however, our results suggest that it has potential as a tumor marker. Considering the association between CA724 and CRC, we may surmise the presence of similar associations between other STMs and carcinomas.
Our study demonstrated the presence of two opposite trends in the levels of CA724 according to the progression of the clinical CRC stage. As was mentioned previously, there was an ascending gradient among CC patients and a descending gradient among RC patients. These two opposite trends possibly reflect biological, advancing and metastatic differences between CC and RC. Due to the similarities in morphology and configuration and the fact that one is considered to be the continuation of the other, CC and RC are often considered as a single disease entity. However, an increasing number of studies refer to the differences between these two types of cancer. Firstly, the colon embryologically originates from the midgut and hindgut, whereas the rectum originates from the cloaca. Furthermore, relevant studies have demonstrated that there were differences regarding blood supply, biological function, histochemical reactions and the level of mRNA expression (21) (22) (23) (24) (25) (26) . Those studies indicated that the normal colon and rectum are different. A previous study also reported that the prognosis of CC is better compared to that of RC and that RC exhibits a higher expression of CEA15. Additionally, a gene-level analysis demonstrated that methylation and mutations were more common in the right colon (27) . All those results suggested that there are biological differences between CC and RC. The exact mechanism underlying the descending gradient in the CA724 levels among RC patients has not been elucidated.
Although this study included a small number of patients, the results regarding the association between CA724 levels and CRC patients were considered to be statistically significant. Due to the small number of stage Ⅰ CC patients (n=6), further investigations are required to confirm these findings. Furthermore, the exact nature of the association and the underlying pathophysiological mechanisms of the opposite trends of serum CA724 in CC and RC require further investigation by future large prospective studies.
In conclusion, we demonstrated a close correlation between serum CA724 levels and tumor migration in CRC. The opposite variation tendencies of CA724 levels in the different evolution groups of CC and RC may reflect the differences between these two types of cancer. The evaluation of serum CA724 levels, particularly elevation in patients with CC, may be of monitoring and predictive value and may also assist in the development of treatment strategies for CRC patients.
